Cited by CrossRef (36)

  1. Kyung‐Soo Kim, Sangmo Hong, Hong‐Yup Ahn, Cheol‐Young Park. Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease. Obesity 2022;30:1279
    https://doi.org/10.1002/oby.23438
  2. Sarah Altajar, Na Wang, Max P. Rosenthaler, Joanne M. Murabito, Michelle T. Long. NAFLD Associates with Sarcopenia Defined by Muscle Mass and Slow Walking Speed: A Cross-Sectional Analysis from the Framingham Heart Study. JCM 2023;12:7523
    https://doi.org/10.3390/jcm12247523
  3. Yu Jin Cho, Youn-Hee Lim, Jae Moon Yun, Hyung-Jin Yoon, Minseon Park. Sex- and age-specific effects of energy intake and physical activity on sarcopenia. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-66249-6
  4. Han Na Jung, Yun Kyung Cho, Hwi Seung Kim, Eun Hee Kim, Min Jung Lee, Joong-Yeol Park, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung. Association of serum gamma-glutamyl transferase with myosteatosis assessed by muscle quality mapping using abdominal computed tomography. Clinical Imaging 2023;93:4
    https://doi.org/10.1016/j.clinimag.2022.10.009
  5. Yoowon Kwon, Su Jin Jeong. Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. JCM 2020;9:3355
    https://doi.org/10.3390/jcm9103355
  6. Alessandro Mantovani, Giovanni Targher, Giacomo Zoppini. Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. Clinics in Geriatric Medicine 2020;36:527
    https://doi.org/10.1016/j.cger.2020.04.010
  7. Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung. The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population. J cachexia sarcopenia muscle 2022;13:2953
    https://doi.org/10.1002/jcsm.13099
  8. Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022;20:2809
    https://doi.org/10.1016/j.cgh.2021.12.002
  9. Joana RIGOR, Raquel VASCONCELOS, Rogério LOPES, Teresa MOREIRA, Pedro BARATA, Daniela MARTINS-MENDES. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease. Minerva Gastroenterol 2023;69
    https://doi.org/10.23736/S2724-5985.22.03097-2
  10. Ting Zhou, Junzhao Ye, Ling Luo, Wei Wang, Shiting Feng, Zhi Dong, Shuyu Zhuo, Bihui Zhong. Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD. Skeletal Muscle 2023;13
    https://doi.org/10.1186/s13395-023-00333-z
  11. Chenbing Liu, Nan Li, Di Sheng, Yahong Shao, Lihong Qiu, Chao Shen, Zhong Liu. Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population. Lipids Health Dis 2024;23
    https://doi.org/10.1186/s12944-024-02100-5
  12. Goh Eun Chung, Hyo Eun Park, Heesun Lee, Min Joo Kim, Su-Yeon Choi, Jeong Yoon Yim, Ji Won Yoon. Sarcopenic Obesity Is Significantly Associated With Coronary Artery Calcification. Front. Med. 2021;8
    https://doi.org/10.3389/fmed.2021.651961
  13. Chao Deng, Qifeng Ou, Xuee Ou, Ding Pan. Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis. BMJ Open 2024;14:e078933
    https://doi.org/10.1136/bmjopen-2023-078933
  14. Chihiro Tanikawa, Miki Kurata, Noriko Tanizaki, Mika Takeuchi, Edlira Zere, Keisuke Fukuo, Kenji Takada. Influence of the nutritional status on facial morphology in young Japanese women. Sci Rep 2022;12
    https://doi.org/10.1038/s41598-022-21919-5
  15. Goh Eun Chung, Ji Won Yoon. Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:160
    https://doi.org/10.7570/jomes20046
  16. Pegah Golabi, Lynn Gerber, James M. Paik, Rati Deshpande, Leyla de Avila, Zobair M. Younossi. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Reports 2020;2:100171
    https://doi.org/10.1016/j.jhepr.2020.100171
  17. Han Na Jung, Chang Hee Jung, You-Cheol Hwang. Sarcopenia in youth. Metabolism 2023;144:155557
    https://doi.org/10.1016/j.metabol.2023.155557
  18. Yun Kim. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life 2021;11:250
    https://doi.org/10.3390/life11030250
  19. Sophia Marie-Therese Schmitz, Lena Schooren, Andreas Kroh, Alexander Koch, Christine Stier, Ulf Peter Neumann, Tom Florian Ulmer, Patrick Hamid Alizai. Association of Body Composition and Sarcopenia with NASH in Obese Patients. JCM 2021;10:3445
    https://doi.org/10.3390/jcm10153445
  20. Goh-Eun Chung, Hyo-Eun Park, Min-Joo Kim, Min-Sun Kwak, Jong-In Yang, Su-Jin Chung, Jeong-Yoon Yim, Ji-Won Yoon. The Association between Low Muscle Mass and Hepatic Steatosis in Asymptomatic Population in Korea. Life 2021;11:848
    https://doi.org/10.3390/life11080848
  21. Ting Zhou, Junzhao Ye, Yansong Lin, Wei Wang, Shiting Feng, Shuyu Zhuo, Bihui Zhong. Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults. Br J Nutr 2023;130:1373
    https://doi.org/10.1017/S0007114523000399
  22. Chan-Hee Jung. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:158
    https://doi.org/10.7570/jomes20018
  23. Hsien-Hao Huang, Tse-Yao Wang, Shan-Fan Yao, Pei-Ying Lin, Julia Chia-Yu Chang, Li-Ning Peng, Liang-Kung Chen, David Hung-Tsang Yen. Gastric Mobility and Gastrointestinal Hormones in Older Patients with Sarcopenia. Nutrients 2022;14:1897
    https://doi.org/10.3390/nu14091897
  24. Hyo Eun Park, Goh Eun Chung, Heesun Lee, Min Joo Kim, Su-Yeon Choi, Wonjae Lee, Ji Won Yoon. Significance of Low Muscle Mass on Arterial Stiffness as Measured by Cardio-Ankle Vascular Index. Front. Cardiovasc. Med. 2022;9
    https://doi.org/10.3389/fcvm.2022.857871
  25. Milian Chen, Ying Cao, Guang Ji, Li Zhang. Lean nonalcoholic fatty liver disease and sarcopenia. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1217249
  26. Hyuktae Kwon. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:76
    https://doi.org/10.7570/jomes19068
  27. Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. IJMS 2023;24:7517
    https://doi.org/10.3390/ijms24087517
  28. Yun Yi, Chun Wang, Yang Ding, JiangHua He, YuQing Lv, Ying Chang. Diet was less significant than physical activity in the prognosis of people with sarcopenia and metabolic dysfunction-associated fatty liver diseases: Analysis of the National Health and Nutrition Examination Survey III. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1101892
  29. Shelley E. Harris, Toryn M. Poolman, Anastasia Arvaniti, Roger D. Cox, Laura L. Gathercole, Jeremy W. Tomlinson. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020;319:G345
    https://doi.org/10.1152/ajpgi.00055.2020
  30. Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M. Fernández-Costa, Alice Senni, Rajiv Jalan, Javier Ramón-Azcón. Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver. Biomedicines 2022;10:958
    https://doi.org/10.3390/biomedicines10050958
  31. Evangelos Cholongitas, Dimitrios Tsilingiris, Panagiota Diamantopoulou, Elpida Mastrogianni, Anastasios Tentolouris, Dimitrios Karagiannakis, Ioannis Moyssakis, George V. Papatheodoridis, Nikolaos Tentolouris. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. Hormones 2022;21:133
    https://doi.org/10.1007/s42000-021-00334-x
  32. David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obesity Science & Practice 2021;7:629
    https://doi.org/10.1002/osp4.509
  33. Goh Eun Chung, Ji Won Yoon. Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:78
    https://doi.org/10.7570/jomes20009
  34. Junghyun Noh. Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease. JOMES 2020;29:1
    https://doi.org/10.7570/jomes20017
  35. Tiziana Fernández-Mincone, Felipe Contreras-Briceño, Maximiliano Espinosa-Ramírez, Patricio García-Valdés, Antonio López-Fuenzalida, Arnoldo Riquelme, Juan Pablo Arab, Daniel Cabrera, Marco Arrese, Francisco Barrera. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Review of Gastroenterology & Hepatology 2020;14:1141
    https://doi.org/10.1080/17474124.2020.1810563
  36. Ji-Yeon Seo, Jung-Ho Bae, Min-Sun Kwak, Jong-In Yang, Su-Jin Chung, Jeong-Yoon Yim, Seon-Hee Lim, Goh-Eun Chung. The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease. Biomedicines 2021;9:1401
    https://doi.org/10.3390/biomedicines9101401